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1. Introduction 
According to the statement "prevention is better than cure" the consumers’ concern about 
their health increases, which is reflected in the sales of products supporting the immune 
system. Such products are made of milk and colostrum, especially the immune proteins 
isolated from them. These proteins are increasingly used to enrich baby food, dietary 
medications or high-protein formulas recommended for convalescents and athletes. 
Furthermore, these proteins are used in pharmacology and cosmetology. They play a major 
role in the transmission of passive immunity to the offspring and protect the host mammary 
gland (Gapper et al., 2007; Stelwagen et al., 2009). This group of proteins include 
immunoglobulins, lactoferrin, lactoperoxidase and lysozyme. Increasingly, these milk 
components are used by humans for the prophylactic or therapeutic aims. 
Content of antibacterial proteins in the diet is one of the factors determining the normal 
immune response of the organism. Lactoferrin, lysozyme and immunoglobulins are 
therefore essential components of milk from the consumers’ viewpoint. In order to meet 
the demands of the consumers, the dairy industry should seek high quality raw materials 
tested for biologically active compounds. It is therefore important to know the factors that 
determine their content in cow milk. In this study the influence of selected factors on 
content of lactoferrin, lysozyme and immunoglobulins G in cow milk is discussed. 
2. Characteristics of milk proteins with the antibacterial properties 
2.1 Immunoglobulins 
Very important group of proteins exhibiting antimicrobial activity are the immunoglobulins. 
These compounds are high molecular globulins, which are present in plasma and body 
fluids. Depending on the physicochemical structure and biological activity, three major 
classes of immunoglobulins are distinguished, i.e. IgG, IgM and IgA. IgG dominate 
(approximately 80 %) in milk of ruminants, while in other mammalian milk, including 
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human, – IgA (approximately 90 %). They determine the specific humoral immunity of a 
body (El-Loly & Farrag, 2007; Pakkanen & Aalto, 1997). During the process of antigens 
binding  as well as phagocytosis or complement activation these proteins are involved in the 
destruction of pathogenic microorganisms, i.e. Escherichia coli, Candida albicans, Clostridium 
difficile, Shigella flexneri, Streptococcus mutans and Helicobacter pylori (Gapper et al., 2007; 
Korhonen, 2004). Furthermore, the immunoglobulins block the action of toxins and viruses. 
In many countries, the specimens on the basis of immunoglobulins are commercially 
available. They are meant for the livestock, mainly for newborn calves and pigs in order to 
prevent gastro-intestinal infections (El-Loly, 2007). Other increasingly popular products are 
also Ig-based products used as food additives (Gapper et al., 2007; Stelwagen et al., 2009; 
Struff & Sprotte, 2008). It has been shown that the supplementation use is beneficial for 
immunity system and prevents diseases of the digestive system (Mehra et al., 2005; Struff & 
Sprotte, 2008). The reduction of diarrhea incidence caused by rotavirus was noted in the 
infants and children up to four years (El-Loly, 2007; Gapper et al., 2007; Rawal et al., 2008). 
Clinical studies have confirmed the efficacy of these specimens in the analgesic therapy in 
patients with fibromyalgia syndrome (Goebel et al., 2008; Struff & Sprotte, 2008). 
2.2 Lactoferrin 
Lactoferrin is a glycoprotein with a molecular weight of about 80 kDa. Due to the size and 
construction, it belongs to the transferrin family, which has a specific ability to bind iron 
(Baker & Barker, 2005; Legrant et al., 2008). It occurs as a single polypeptide chain which 
consists of about 690 amino acids (Baker & Barker, 2005, Pakkanen & Aalto, 1997). This 
protein was first isolated from milk in the 60s of the previous century. Lactoferrin also 
occurs in other secretions such as saliva, tears, semen, bronchial mucous secretion, digestive 
and genital tract. It is also a component of neutrophil secondary granules from which, 
during an injury, infection and inflammation, it is released into the blood (Artym, 2010, 
Baker & Barker, 2005; Garcia-Mantoya, 2011; Małaczewska & Rotkiewicz, 2007). This protein 
is an essential element of non-specific innate immunity of humans and other mammals 
(Kruzel et al., 2007; Legrant et al., 2008). By binding and sequestrating of iron, lactoferrin 
exhibits antibacterial properties against Gram-positive and Gram-negative bacteria, non-
capsular and capsular viruses as well as various types of fungi and parasites (Małaczewska 
& Rotkiewicz, 2007; Orsi, 2004; Steijns & Hooijdonk, 2000; Wakabayashi et al., 2006). This 
action partially results from the ability of protein to chelate iron (Fe3+ ions), thereby 
removing this element from the environment of microbial growth (Andersen et al., 2003). 
Other mechanisms of the lactoferrin antimicrobial action include direct destruction of 
sheaths and disturbance of bacterial cell metabolism, inhibition of the processes of bacterial 
adherence to body tissues of the host (Hendrixon et al., 2003), inhibition of biofilm 
formation by some bacteria (Singh et al., 2002) and stimulation of the immune system of 
host to fight against pathogens (Artym, 2006). Lactoferrin protects the intestinal epithelial 
cells, and at the same time inhibits the growth of E. coli and other pathogenic intestinal 
bacteria, mainly Enterobacteriaceae, while stimulating the growth of useful intestinal 
microflora of the Bifidobacterium genus (Wakabayashi et al., 2006). This is particularly crucial 
in the case of neonates in whom there is a gradual colonization of the alimentary canal by 
diverse microflora. The development of normal bacterial flora ensures the efficient 
digestion, protects against the pathogenic bacteria development and increases immunity 
(Actor et al., 2009, Griffiths et al., 2003). These factors determined the use of lactoferrin in 
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food for infants (Satue-Gracia et al., 2000; Wakabayashi et al., 2006). An additional 
advantage of lactoferrin in the fight against bacterial infections is the possibility of 
increasing a bacteria sensitivity to certain antibiotics (vancomycin, penicillin) and lowering 
their effective doses. The combination of penicillin with lactoferrin doubles an inhibitory 
activity of antibiotic against Staphylococcus aureus (Diarra et al., 2002). Lactoferrin also shows 
an antiviral activity (Van der Strate et al., 2001; Zimecki & Artym, 2005). In clinical trials, it 
proved to be effective in inhibiting of hepatitis C and B type virus infections (Ikeda et al; 
2000; Ishii et al., 2003; Okada et al., 2002), herpes (Herpes simplex virus) (Andersen et al., 2003; 
Jenssen et al., 2004), HIV (Berkhout et al., 2002; Semba et al., 1998) and rotavirus, which are 
the most important etiological factor for acute diseases running with a diarrhea – major 
cause of mortality of infants and young children in developing countries (Brock, 2002; 
Superti et al., 1999; Van der Strate et al., 2001). Moreover, the synergistic effect with antiviral 
drugs, including interferon, acyclovir and cidofovir, has been observed (Andersen et al., 
2003; Ishii et al., 2003). This effect allows the reduction of the doses of used drugs, 
characterized by high toxicity for the organism. Lactoferrin also has antioxidant capacity 
and prevents the formation of free radicals, as well as regulates the production and release 
of cytokines and tumor necrosis factor – TNF, secreted by macrophages (Małaczewska & 
Rotkiewicz, 2007). In vitro and in vivo research showed that lactoferrin applied direct 
antitumor effect on melanoma and colon cancer cells (Spadaro et al., 2008). Moreover, the 
results suggest that lactoferrin accelerates the formation of bone tissue, and therefore can be 
used in the prevention and treatment of the bone diseases, including osteoporosis. Due to 
cytoprotective properties, it may be involved in slowing down the development of 
neurodegenerative diseases, such as Alzheimer's or Parkinson's disease or multiple sclerosis 
(Blains et al., 2009, Cornish et al., 2004). 
Very important properties of lactoferrin is its resistance to heat and proteolytic enzymes 
(Małaczewska & Rotkiewicz, 2007; Steijns & Hooijdonk, 2000; Wakabayashi et al., 2006). In 
veterinary medicine, what is particularly promising is the use of lactoferrin in aquaculture 
as an agent safe for the environment and human health (Małaczewska et al., 2009). 
2.3 Lysozyme 
Lysozyme (N-acetylmuramide glycanhydrolase, E.C.3.2.1.17) is a low molecular weight 
(14.4 kDa) enzymatic protein from the hydrolase group. It is widely distributed in nature, 
occurring in many body fluids and tissues of living organisms (Fox & Kelly, 2005). The 
highest concentration of the enzyme was found in tears and egg white protein, which is 
currently the basic source of its obtaining on an industrial scale (Cegielska-Radziejewska et 
al., 2008; Chiang et al., 2006; Liśnierowski, 2009; Malicki et al., 2003). The relatively large 
quantities were also noted in human milk (Benkerroum, 2008; Pakkanen & Aalto, 1997; 
Shah, 2000). Lysozyme is natural defense mechanism of an organism. Its action is based on 
disintegrating the bacteria by dissolving the polysaccharide-peptide complex 
(peptidoglycan), which is the main component of the cell wall of numerous bacteria 
(Masschalck & Michiels, 2003). Under natural conditions, the antibacterial activity of 
lysozyme (monomer form) is limited to Gram-positive bacteria, and only after modification 
(despite the reduction of hydrolytic activity) its bactericidal activity extends to Gram-
negative bacteria, including many pathogenic bacteria (Benkerroum, 2008; Chang & Li, 2002; 
Ibrahim et al., 1996; Liśnierowski, 2009; Liśnierowski et al., 2004; Masschalck et al., 2001; 
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Masschalck & Michiels, 2003). Lysozyme is also one of the mechanisms of non-specific, 
humoral immune response (Benkerroum, 2008; Montagne et al., 1998; Pakkanen & Aalto, 
1997). Antibacterial properties of lysozyme causes a considerable interest in its practical 
utilization in many sectors of food industries. It is used primarily as an additive to food, 
showing the preservative properties (Leśnierowski, 2009; Malicki et al., 2003; Proctor and 
Cunningham, 1988; Rosiak & Kołożyn-Krajewska, 2003). During rennet cheese production 
lysozyme limits the growth of butyric fermentation bacteria, especially Clostridium 
tyrobutyricum, causing cheese bloating (Danyluk & Kiev, 2001; Proctor & Cunningham, 
1988). Lysozyme is also used in medical diagnostics, pharmacology and veterinary 
medicine. The enzyme has found a wide application in the therapies of viral and bacterial 
infections, treatment of skin as well as eye diseases, periodontitis, leukemia and cancer 
(Benkerroum, 2008; Proctor & Cunningham, 1988; Zimecki & Artym, 2005). Lysozyme exerts 
an antibiotic adjuvant mechanism of action, and therefore it is often called the endogenous 
antibiotic. It has been shown that the administration of lysozyme enriched milk for the 
premature has a positive influence on their development and speeds up the fight against an 
infection (Zimecki & Artym, 2005). 
3. Antibacterial proteins content in milk of different animal species 
Antibacterial proteins content in milk of different species of livestock is highly variable 
(table 1). The greatest amount of lactoferrin and lysozyme contains human milk, however, it 
is a poor source of immunoglobulins G. The milk of mares, similar to human milk, is 
characterized by a high content of lysozyme, at lower level of lactoferrin. Milk of other 
livestock species contains considerably less of these proteins, however, in this group of 
animals the camel and cow milk is distinguished by a higher content of lactoferrin and the 
ovine milk – lysozyme. The richest source of IgG is the camel milk. It is worth noting that 
the lactoferrin derived from human milk reveals the lowest antibacterial activity, while the 
highest from the camel milk (Coness et al., 2008). A changeability within the species is 
primarily due to the differences in lactation period, feeding regimen, number of analyzed 
samples, breeds, and methods of analysis. 
 
 
 
Specification Lactoferrin Lysozyme Immunoglobulins G 
Human 700-2000 100-890 40-54 
Cow 80-500 0.37-0.60 100-800 
Buffalo 50-320 0.13-0.15 460-1300 
Camel 200-728 0.73-5.00 2000 
Goat 98-150 0.25 100-400 
Ewe 140 1-4 500 
Mare 820 400-890 390 
Table 1. Average concentrations of lactoferrin, lysozyme and immunoglobulins G in milk of 
different species (mg/l) (Dračková et al., 2009; El-Hatmi et al., 2007; Konuspayeva et al., 
2008; Liu et al., 2009; Pandya & Khan, 2006; Park et al., 2007; Stelwagen et al., 2009; Wheeler 
& Hodgkinson, 2007) 
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4. Materials and methods 
4.1 Materials 
4.1.1 Animals 
The studies were conducted throughout four successive years (2006-2009) on milk samples 
collected from seven different breeds of dairy cows maintained in Poland, i.e. three breeds 
with an international meaning (Polish Holstein-Friesian, Simental and Jersey) as well as four 
local breeds (Polish Red, Whitebacks, Polish Black and White and Polish Red and White).  
The Polish Holstein-Friesian, Simental and Jersey cows were managed under an intensive 
system in free-stall barns. An animal feeding system, established over both the winter and 
summer season, was based on a Total Mixed Ration – TMR (corn silage, haylage and feed 
concentrate). It should be also mentioned that one group of the Simental cows, included into 
the research, was maintained in the Southern Poland and a conventional feeding system was 
used. In the summer the animals grazed pasture ad libitum, and in the winter they received 
haylage, hay, and concentrate. However, the local breeds of cows are predominantly 
managed in small-sized farms in South-Eastern Poland (mountain, submountain or boggy 
terrains). Owing to small number and genetic distinction, the animals of these breeds are 
included into the genetic resources conservation programme (Litwińczuk et al., 2006). These 
cows were housed in a conventional system, i.e. in tie-stall barns. The summer feeding was 
based on pasture forage, i.e. green fodder comprising grasses and legumes supplemented by 
hay or straw, while the winter feeding on haylage and hay with fodder beet additive. In all 
the farms, a feed ration was supplemented with a feed concentrate.  
4.1.2 Milk samples collection 
Milk samples were collected individually from each cow during trial milking which 
occurred twice a year, once in the summer period and again in the winter. A total of 3,105 
milk samples were examined (table 2). 
 
Breed Summer season Winter season 
Intensive system 
Polish Holstein-Friesian 502 539 
Simental 215 242 
Jersey 184 192 
Total 901 973 
Conventional system 
Simental 221 207 
Polish Red 159 126 
Whitebacks 133 117 
Polish Black and White 91 75 
Polish Red and White 54 48 
Total 658 573 
Table 2. Number of milk samples taken to the research 
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4.2 Chemical analysis 
All milk samples were transported to the laboratory of the Department of Commodity 
Science and Processing of Animal Raw Materials, University of Life Sciences in Lublin 
(Poland). Each milk sample was analyzed for somatic cell count (SCC) using flow cytometry 
technology – Somacount 150 apparatus (Bentley, USA). In 2,662 samples the SCC did not 
exceed 400,000 cells/ml, i.e. the standard accepted by the European Parliament and the 
Council of 29 April 2004 (EC Regulation No. 853/2004 on the specific hygiene rules for food 
of animal origin). These milk samples were included solely into the research evaluating an 
effect of cow breed,  age of cows and stage of lactation and feeding system. 
Lactoferrin and lysozyme contents were determined using the reversed-phase high-
performance liquid chromatography (RP-HPLC) with UV-Vis detector. From each sample of 
raw milk was taken 50 ml and adjusted to pH 4.6 with 0.1 mol/l HCl, and allowed to stand 
at room temperature for about one hour to allow for the acid precipitation of caseins. 
Consequently, whey (7 ml) was taken from each of the samples separately and then 
centrifuged at 10,000 rpm for 15 min. Finally, whey solutions were filtered through paper 
quality filter discs (diameter: 125 mm, density: 65 g/m2, grade: 3 hours (Munktell, 
Germany)) and 0.20-μm disposable sterile filters (Millipore type GSTF, USA). The 
supernatants in vials were kept refrigerated until further analysis, and were injected into the 
chromatograph at the suitable time (in the amount of 20 μl). Protein separation was 
performed on liquid chromatography ProStar 210 model and UV-Vis ProStar 325 detector 
(Varian, USA). The measurements were carried out using the water/acetonitrile mobile 
phase at gradient elution and column NUCLEOSIL 300-5 C18 (Varian, USA) of 250 mm 
length and 4.6 mm diameter. The mobile phase was solvent A (90% water, 10% acetonitryle) 
and solvent B (90% acetonitryle, 10% water), purchased from Sigma (Germany). The 
solvents were filtered through 0.45-μm filters (Millipore, USA) and degassed by using 
ultrasounds. The total analysis time for a single sample was 35 min at 205 nm wavelength 
with column temperature of 37°C. The analyses of reference substances were conducted 
under the same conditions. On the grounds of the obtained chromatograms, using program 
Star 6.2 Chromatography Workstation (Varian, USA), the qualitative and quantitative 
identification of each substance was performed followed by their concentration 
determination. Calibration of the chromatographic system for whey proteins determination 
was carried out by the external standard method. For this purpose, each protein was 
calibrated individually by injecting solutions of the standards (20 μl). The standards were 
purified proteins, i.e. lactoferrin (90 %) from bovine milk and lysozyme (95 %) from hen egg 
whites, which were purchased from Sigma (Germany). All chemicals were of HPLC 
analytical grade. Concentrations of lactoferrin and lysozyme solutions ranged from 0 to 200 
mg/l and from 0 to 20 µg/l respectively, and were prepared to create the calibration curves. 
The limits of quantification LOQ (for lactoferrin – 40 mg/l and for lysozyme – 2.8 µg/l) and 
detection LOD (for lactoferrin – 8.7 mg/l and lysozyme – 0.9 µg/l) were determined. The 
immunoglobulin G (IgG) levels were established by the aid of radial immunodiffusion 
technique with Bovine IgG LL tests (The Binding Site, Birmingham, UK). Control samples, 
provided in the IgG LL set, were used before the test samples. 
4.3 Statistical analysis 
Data are given as mean ± standard deviation. The obtained results were analyzed by the 
General Linear Model (GLM) – factorial ANOVA procedures of Statsoft Inc. Statistica ver.6 
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(Statsoft Inc. 2003). It was done on the grounds of one-way and multi-way analysis of 
variance with interaction, using Tukey’s HSD procedure.  
The following factors were taken into consideration: 
- cow  breed 
Seven breeds of cows kept in Poland, i.e. three breeds of international importance (Polish 
Holstein-Friesian, Jersey and Simmental) and four local breeds, kept only in Poland (Polish 
Red, Whitebacks, Polish Black and White and Polish Red and White). 
- age of cows and stage of lactation  
Age classes, mostly noticed as subsequent lactation: I, II, III and IV. 
Stage of lactation, i.e. up to 120 days, from 121 to 200 and from 201 to 305 days of lactation. 
- feeding system 
Two feeding systems solely for the Simental cows were distinguished: 
• conventional (in the summer cows grazed the pasture (ad libitum), in the winter 
cows were fed with haylage and hay),  
• intensive (total mixed ration (TMR) feeding system was used throughout the year). 
- somatic cell count. 
The research material for each breed was split into four groups according to somatic cell 
count detected in the milk samples: Group I – up to 100,000 cells/ml, Group II – 101,000-
400,000 cells/ml, Group III – 401,000-500,000 cells/ml, and Group IV – 501,000-1,000,000 
cells/ml. Next, to regulate the SCC distribution, the SCC data were transformed into log 10 
SCC for each sample before statistical analysis could take place. 
5. Factors affecting the content of lactoferrin, lysozyme and 
immunoglobulins G 
5.1 Cow breed 
It has been shown that among the many breeds of cows involved in milk production in 
Poland, the cows of local breeds produce a raw material with a higher content of 
antibacterial proteins, such as lactoferrin and immunoglobulins G. The highest 
concentration of these proteins was found in the milk of Polish Red cows (128.7 and 558.1 
mg/l). A slightly lower level of them was established in milk of Polish Red and White (120.9 
and 545.6 mg/l) as well as Whitebacks (115.2 and 540.2 mg/l). Significant amounts of 
lactoferrin and immunoglobulins G were also reported in the milk of Simental cows (116.74 
and 579.9 mg/l), managed under an intensive production system. However, the milk 
obtained from two breeds of cows with the greatest importance in milk production, both in 
Poland and the world, i.e. Holstein-Friesian and Jersey, was a poorer source of these 
proteins (table 3). Simultaneously, milk of Jersey cows characterized by a high content of 
lysozyme (13.02 µg/l). Milk of local cow breeds contains only slightly less lysozyme (from 
10.79 to 12.42 µg/l). The comparable to the present research lactoferrin content in raw milk 
from Swedish farms, i.e. 90 mg/l (70-110 mg/l) was obtained by Lindmark-Månsson et al. 
(2003). In another Swedish study (Wedholm et al., 2006), both in the milk of Swedish 
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Holstein cows, and Swedish Red-White, established 120.0 mg/l of lactoferrin. Higher level of 
this protein (145.66-204.89 mg/l) reported Wielgosz-Groth et al. (2009) in the milk of Polish 
Holstein-Friesian cows. A substantially lower this protein content (7.30-14.73 mg/l) in milk 
from Black-White variety cows with 50-75 % share of Holstein-Friesian genes obtained 
Reklewska et al. (2003). The authors, however, noted the closest to the present study lysozyme 
concentration. That milk, depending on the feeding system, contained from 12.54 to 16.43 µg/l 
of lysozyme. Significantly more of this protein (70 µg/l) found Elegamy et al. (1996). Tsuji et al. 
(1990), analyzing lactoferrin concentration in the colostrum obtained from four breeds of cows 
in Japan, showed a higher share of this protein in the colostrum produced by Holstein-Friesian 
and Jersey cows (1.96-2.11 mg/ml), compared to Japanese Brown and Japanese Black (0.40-0.56 
mg/ml). Newstead (1976) determined IgG concentration in milk of Jersey and Friesian cows. 
The author found (compared to the present research) a substantially lower level of this protein 
in milk of Jersey cows, i.e. 0.32 g/l. While milk gained from Friesian cows contained 0.46 g/l 
IgG. In the research of Levieux and Ollier (1999) revealed the comparable to the present study 
concentration of IgG. Krukowski et al. (2006) in the milk from Black and White variety cows 
with 50-75 % Holstein-Friesian genes reported higher level of these proteins – 628 mg/l. 
Whereas, in milk from the Polish Holstein-Friesian Black and White variety cows, the 
differences in IgG content reached over 200 mg/l. Murphy et al. (2005) showed a breed 
influence on concentration of IgG in colostrum of beef cows (from 75.7 mg/ml for the 
Limousin to 95.5 mg/ml for Charolais). 
 
Specification 
Lactoferrin 
(mg/l) 
Lysozyme 
(µg/l) 
Immunoglobulins G 
(mg/l) 
Polish Holstein- 
Friesian  
88.42A 
14.72 
8.22A 
0.99 
423.6A 
18.4 
Simental 
116.74BC 
16.54 
9.84AB 
1.88 
579.9B 
16.5 
Jersey 
103.48AB 
15.68 
13.02B 
2.21 
508.6AB 
29.1 
Polish Red 
128.7C 
17.35 
12.17B 
5.76 
558.1B 
22.4 
Whitebacks 
115.2BC 
21.01 
12.42B 
3.38 
540.2B 
46.1 
Polish Black and 
White 
105.9AB 
19.37 
10.79AB 
4.82 
530.2B 
29.3 
Polish Red and 
White 
120.9BC 
19.22 
11.51AB 
5.23 
545.6B 
48.3 
A, B, C – differences significant at P≤0.01  
Table 3. Effect of breed on the antimicrobial protein content in bovine milk  
(mean ± standard deviation) (Król et al., 2007, 2010a, 2010b; unpublished data) 
5.2 Age of cows and stage of lactation 
Age of cows (usually referred to as the subsequent lactation) and stage of lactation are the 
main physiological factors affecting the productivity and chemical composition of cow milk. 
It has been shown that the poorest source of analyzed antimicrobial proteins proved to be 
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the milk obtained from primiparous cows (table 4). The lowest level of IgG was found in I 
lactation (454.8 mg/l). In subsequent lactations share of these compounds increased 
gradually, with significant differences (P≤0.01) occurred only in the IV lactation. Lysozyme 
content progressed successively with the lactations, with peaks reported in IV lactation. 
Whereas, the highest lactoferrin concentration was observed in milk from cows at II and IV 
lactation, 107.18 and 115.61 mg/l, respectively. In the studies of Levieux & Ollier (1999), 
similarly to the present research, the primiparous cows produced significantly less IgG, as 
compared to cows at II-IV lactation (P≤0.05) and older (P≤0.01). The results of Guliński et al. 
(2006) and Mian-Bin Wu & Xu Yin-Jun (2009) confirmed the higher concentration of these 
proteins in milk and colostrum produced by the multiparous cows. It was also noted that in 
the subsequent lactations were significant differences in lactoferrin content (Back & 
Thompson, 2005; Hagiwara et al., 2003; Liu et al., 2009; Tsuji et al., 1990). Older cows, i.e. in 
IV lactation, produced milk with significantly higher concentration of this protein, 
compared to younger ones (Back & Thompson, 2005; Liu et al., 2009; Tsuji et al., 1990). 
Whereas, Hagiwara et al. (2003) reported significantly lower lactoferrin concentration in V 
lactation in relation to II (P≤0.01) and III (P≤0.05) lactation. 
 
Specification 
Subsequent lactation 
I II III IV 
Lactoferrin 
(mg/l) 
89.39A 
17.89 
107.18B 
18.26 
99.50AB 
16.32 
115.61B 
19.33 
Lysozyme 
(µg/l) 
7.56a 
2.11 
9.29ab 
1.68 
9.87b 
2.13 
10.28b 
2.36 
Immunoglobulins G 
(mg/l) 
454.8A 
16.4 
511.7AB 
21.5 
513.2AB 
19.7 
541.1B 
25.9 
a, b – differences significant at P≤0.05; A, B – differences significant at P≤0.01  
Table 4. Effect of subsequent lactation on the antimicrobial protein content in bovine milk  
(mean ± standard deviation) (Król et al., 2010a) 
Antibacterial protein level also underwent significant changes throughout the lactation 
period (table 5). Milk collected during the first months of lactation was characterized by the 
lowest lactoferrin and lysozyme content. Significantly more of these proteins amounts were 
determined in the late stage of lactation, i.e. by 48.11 mg/l (P≤0.01) and 3.12 mg/l (P≤0.05). 
Milk obtained from this lactation stage also contained the highest immunoglobulins G level 
(553.8 mg/l). During the first stages of lactation, these proteins content was significantly 
lower (P≤0.05), i.e. ranged from 70.6 mg/l (early stage) to 78.4 mg/l (middle stage). 
Concentration of IgG investigated by Caffin et al (1983) was also noted to change (alike in 
the present study) during the lactation course. In the early (30 days) and the middle stage 
(150 days) of lactation, there were found comparable values, i.e. 0.37 and 0.38 mg/ml. The 
significantly higher IgG content was reported in milk obtained in late lactation (270 days) – 
0.60 mg/ml. Changes in IgG level in milk during lactation also confirmed the research of 
Liu et al. (2009). Wielgosz-Groth et al. (2009) showed an increase in the content of lactoferrin 
in milk of Jersey cows during lactation. Its concentration ranged from 51.91 µg/ml in the 
first month of lactation to 259.43 µg/ml in the tenth one. The changes in these protein 
content thought the lactation were also reported by Hiss et al. (2008), who analyzed goat 
milk. Until 32nd lactation week the lactoferrin level maintained between 10 to 28 mg/ml, 
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then it successively progressed to reach over 100 µg/ml in 44th lactation week. In human 
milk also stated that the lactoferrin and lysozyme concentration increase in the duration of 
lactation (Hennart et al., 1991; Montagne et al., 2001). Cheng et al. (2008) found a high 
correlation coefficient between the content of lactoferrin and lactation stage (r = 0.557). 
 
Specification 
Lactation stage 
<120 days 121-200 days 201-305 days 
Lactoferrin 
(mg/l) 
76.12A 
15.69 
109.50AB 
19.58 
124.23B 
21.36 
Lysozyme 
(µg/l) 
8.16a 
2.25 
9.18ab 
2.64 
11.28b 
3.29 
Immunoglobulins  G  
(mg/l) 
483.2a 
21.3 
475.4a 
19.8 
553.8b 
23.6 
a, b – differences significant at P≤0.05; A, B – differences significant at P≤0.01 
Table 5. Effect of lactation stage on the antimicrobial protein content in bovine milk (mean ± 
standard deviation) (Król et al., 2010a) 
5.3 Feeding system 
Among the environmental factors, the feeding system has the major impact on the milk 
yield and its chemical composition. For example the Simental cows, for which it was 
possible to distinguished two groups of feeding system, the significant differences in the 
content of these proteins were showed between the groups (table 6). Milk of cows grazing 
the pasture characterized by a higher content of lactoferrin (by 27.9 mg/l), lysozyme (by 0.65 
mg/l), as well as IgG (by 39.6 mg/l). Higher level of the functional whey proteins in milk of 
cows grazing the pasture also obtained King et al. (2007) and Reklewska et al. (2003). 
Different results reported Wielgosz et al. (2009). The authors found lower levels of 
lactoferrin in the milk of cows kept on the pasture (145.66-148.83 mg/l) in comparison with 
milk of cows fed in barns (174.63-204.89 mg/l). Turner et al. (2003) also reported higher 
levels of lactoferrin in milk of cows fed the TMR system in relation to milk of cows grazing 
the pasture. In the subsequent study (Turner et al., 2007) the content of lactoferrin in milk of 
cows using the pasture in various degree was compared. Significantly (P≤0.05) higher 
lactoferrin yield (in g per day) was found in the milk of cows having unrestricted access to 
pasture (ad libitum). Mackle et al. (1999) showed that a pasture supplementing with maize 
grain and silage led to slightly decreasing of IgG content. 
Specification 
Feeding system
Traditional  system Intensive system 
Lactoferrin 
(mg/l) 
127.52B
19.1
110.71A 
17.8
Lysozyme 
(µg/l) 
10.90b
2.4 
10.25a 
2.4 
Immunoglobulins G 
(mg/l) 
602.4B
40.1
562.8A 
31.6
a, b – differences significant at P≤0.05; A, B – differences significant at P≤0.01  
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Table 6. Effect of feeding system on the antimicrobial protein content in bovine milk 
(mean ± standard deviation) (Król et al., 2008; Brodziak, 2011; unpublished data) 
5.4 Somatic cell count 
Somatic cell count is a commonly recognized indicator of bovine udder health, milk quality 
and its technological usability. SCC is also one of the criteria for admission to the purchase 
of milk. According to many authors and bovine quarter producing milk with the SCC over 
200,000 cells/ml shows the symptoms of subclinical mastitis. In Poland and other EU 
countries in accordance with the applicable decree, i.e. Regulation (EC) No. 853/2004, raw 
cow milk should not contain more than 400,000 somatic cells/ml. SCC has been shown to 
influence the immunoactive protein content. With the growth of SCC significantly increased 
the concentration of lactoferrin, lysozyme and IgG (table 7). Milk with the highest number of 
somatic cells (group IV) contained most of these proteins. In comparison to milk of cows 
belonging to I group, these differences were for lactoferrin – 26.66 mg/l (i.e. 32.6 % value of 
group I), lysozyme – 5.14 µg/l (60.2 %) and IgG – 219.4 mg/l (42.6 %). A substantial effect of 
SCC on immunoactive proteins content was confirmed by relatively high positive values of 
calculated correlation coefficients. For the content of lactoferrin: r = 0.65, for lysozyme r = 
0.63 and for immunoglobulins G r = 0.79. Urech et al. (1999), in the study of quarter milk, 
indicated similar tendencies when 100,000 cells/ml were recognized as the threshold of 
somatic cell count. Quarter milk obtained from clinically healthy mammary glands 
contained an average of 84,000 of somatic cells/ml, whereas the milk from infected glands 
had 293,000 cells/ml (P<0.001). The authors showed the significant growth of lactoferrin (by 
0.45 %) in milk from the affected udder. Similarly, Hamann (2002) defined “the gold 
standard” for a cell count to be up to 100,000 somatic cells/ml. Counts that reached above 
this point provided evidence of disturbed milk secretion that would lead to a reduced 
production of daily milk, changes in its chemical composition, and a deterioration of the 
processing properties of the milk. According to Lindmark-Månsson et al. (2000, 2006) an 
exceeding 5,000 cells/ml for somatic cell count limit leads to increase of lactoferrin content 
in milk, and a close relationship between this milk component and the status of udder 
health has been confirmed by very high correlation coefficients between milk lactoferrin 
concentration and somatic cell counts (r = 0.962 and r = 0.918 at P<0.001), obtained in two 
independent studies. A significant increase (P<0.05) of lactoferrin content with concurrent 
progression of a mammary gland disease was also noted in goat and buffalo milk (Leitner et 
al., 2004; Piccinini et al., 2006). The effect of SCC growth on the content of IgG was reported 
also by other authors (Caffin et al., 1983; Liu et al., 2009). 
 
Specification 
SCC group 
I II III IV 
Lactoferrin 
(mg/l) 
81.84a 
17.2 
82.56a 
18.4 
91.07ab 
19.6 
108.5b 
20.2 
Lysozyme 
(µg/l) 
8.65A 
1.74 
9.68AB 
1.46 
11.54AB 
2.05 
13.79B 
2.68 
Immunoglobulins G 
(mg/l) 
514.6a 
18.9 
520.9a 
22.7 
587.1ab 
35.5 
734.0b 
54.3 
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a, b – differences significant at P≤0.05; A, B, C – differences significant at P≤0.01 
Table 7. Effect of SCC on the antimicrobial protein content in bovine milk (mean ± standard 
deviation) (Litwińczuk et al., 2011; unpublished data) 
Summarized in table 8 the results of two-way analysis of variances indicate significant 
influence of the analyzed factors (breed, age of cows, stage of lactation, feeding system, 
SCC) on the content of individual proteins. For lactoferrin content the significant 
interactions between breed of cows and stage of lactation as well as breed and SCC were 
also found. In the case of the following interactions: breed and age of cows as well as age of 
cows x stage of lactation the significant correlations have been shown for lysozyme content. 
 
Factor Lactoferrin Lysozyme Immunoglobulins G 
Breed 0.004 0.010 0.002 
Age of cows 0.000 0.000 0.002 
Stage of lactation 0.000 0.021 0.030 
Feeding system 0.001 0.031 0.008 
SCC 0.015 0.000 0.025 
Breed x age of cows 0.521 0.015 0.150 
Breed x stage of 
lactation 
0.029 0.365 0.131 
Breed x SCC 0.000 0.553 0.777 
Age of cows x stage 
of lactation 
0.075 0.003 0.778 
Age of cows x SCC 0.363 0.470 0.951 
Stage of lactation x 
SCC 
0.893 0.560 0.817 
Table. 8. Results of one-way and two-way variances analysis for chosen milk proteins 
(P values) (Litwińczuk et al., 2011; unpublished data) 
6. Conclusion 
Content of the antibacterial proteins is determined by the genetic factors (breed of cows), 
environmental (feeding system and SCC) as well as physiological (age of cows and stage of 
lactation). Significant increase of these proteins concentration could be achieved by a 
production system changing, i.e. the introduction of pasture.  
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